Sanctuary Advisors LLC Has $4.11 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Sanctuary Advisors LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 3.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,680 shares of the company’s stock after purchasing an additional 407 shares during the quarter. Sanctuary Advisors LLC’s holdings in HCA Healthcare were worth $4,106,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of HCA. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth approximately $39,000. Activest Wealth Management raised its stake in shares of HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares during the last quarter. Canoe Financial LP purchased a new stake in shares of HCA Healthcare in the third quarter worth approximately $41,000. Capital Performance Advisors LLP purchased a new stake in shares of HCA Healthcare during the third quarter valued at approximately $41,000. Finally, Pinnacle Bancorp Inc. increased its position in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after acquiring an additional 50 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

NYSE:HCA opened at $316.07 on Friday. The firm has a market capitalization of $78.49 billion, a price-to-earnings ratio of 14.39, a P/E/G ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The stock has a fifty day moving average of $313.53 and a 200 day moving average of $350.84. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the company earned $5.90 earnings per share. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.91%. HCA Healthcare’s dividend payout ratio is presently 12.02%.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of research analyst reports. TD Cowen decreased their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Bank of America decreased their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Morgan Stanley reduced their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Oppenheimer increased their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Finally, KeyCorp reduced their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.